Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
James J /ky Obrien is Director at Eastman Chemical Company. OQRO lists 2 transactions filed with the SEC under this name, the latest on Oct 9, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
1
1 buy, median −17.7 pts vs S&P 500, beat it 0 of 1 time.
Average −17.7 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Aug 28, 2025 to Aug 28, 2025, measured from the first close after the filing. Past results, not a forecast.
1 purchase disclosed; 0% of the 1 measured at 90 days finished ahead of the index.
Not ranked: fewer than 10 purchases measured at 90 days. The middle of the 82 ranked insiders is −5.5 pts (median, against the S&P 500).
Eastman Chemical CompanyEMN
2 disclosures · Aug 2025 – Oct 2026 · 1 bought
Oct 7, 2026480disclosed Oct 9
DetailsOfficial recordAug 27, 2025Bought~$100Kdisclosed Aug 28
DetailsEqual weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
As of the latest filing on , James J /ky Obrien reported holding 6,828 shares of Eastman Chemical Company (EMN), worth about $444K at the last close of $65 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Eastman Chemical Company EMN | 6,828 | 6,828 direct | $65 | $444K | Aug 27, 2025 |
Is this James J /ky Obrien’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Aug 27, 2025, James J /ky Obrien reported holding 6,828 shares of Eastman Chemical Company (EMN). At the last close of $65 on Nov 13, 2026, that is about $444K. This is the stake disclosed in filings, not a net worth.
James J /ky Obrien bought shares on the open market in 2008, 2012, 2015, 2016 and 2025 across 4 companies. Sales in 1 of the 19 years since 2008.
In SEC filings since 2008: the latest open-market purchase is from 2025; the latest open-market sale is from 2019.
4 companies: Eastman Chemical Company (EMN, 2025), Humana (HUM, 2008–2019), WESCO International (WCC, 2016), Albemarle Corporation (ALB, 2012–2015).
James J /ky Obrien bought shares on the open market in 2008, 2012, 2015, 2016 and 2025 across 4 companies. Sales in 1 of the 19 years since 2008.
James J /ky Obrien reported 12 open-market purchases and 1 sale since 2008; purchases in 5 different years, most recently 2025.
| Year | Bought | Sold |
|---|---|---|
| 2025 | $100K1×1 trade | — |
| 2019 | — | $855K1×1 trade |
| 2016 | $60K1×1 trade | — |
| 2015 | $53K5×5 trades | — |
| 2012 | $62K2×2 trades | — |
| 2008 | $34K3×3 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
James J /ky Obrien reported 7 open-market purchases and 0 sales here, 2012 to 2015.
James J /ky Obrien reported 3 open-market purchases and 1 sale here, 2008 to 2019.
James J /ky Obrien reported 1 open-market purchase and 0 sales here, 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
